Pure Global
NCT03192228

Impact of a Multidisciplinary Therapeutic Education Program Being Set up for Patients With Type 2 Diabetes Mellitus

Evaluation of a Multidisciplinary Program of Therapeutic Education in Type 2 Diabetes Mellitus Diabetes in Order to Fix Individualized Objectives
Groupe Hospitalier Pitie-Salpetriere·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus, Type 2,Patient Education as Topic
Drug/Device/Intervention
Treatment adequacy score
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Groupe Hospitalier Pitie-Salpetriere
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2011
End date
Sep 01, 2012
Enrollment
120 participants
Primary outcome

Success rate of the therapeutic education program

Summary

Therapeutic education programs allows in diabetic patients to promote self-care and better
 perception of the disease The multidisciplinary program of therapeutic education regroups in
 one day: individual interview, nutritional workshop, self-monitoring blood glucose workshop,
 physical activity and glycemic objectives workshop.
 
 At the end of the program, individual and personalized goals are given to the patient.
 
 This study aims to evaluate this program success rates and the psychological, anamnesis, and
 sociological factors linked to success.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03192228
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03192228 through Pure Global AI's free database. This phase not specified trial is sponsored by Groupe Hospitalier Pitie-Salpetriere and is currently Completed. The study focuses on Diabetes Mellitus, Type 2,Patient Education as Topic. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.